NLRP3 and dermatitis: In IMQ-treated Nlrp3−/− mice, psoriasiform lesions were comparable to those of normal controls; however, caspase-1 activity in the skin was markedly decreased, indicating that the NLRP3 inflammasome was required for caspase-1 activation, but dispensable for skin inflammation (100).